ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 361127 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 361127; 2) Community: the network communities that were significantly associated with the response to NSC 361127; 3) Molecule: the relationships between components within communities and NSC 361127; 4) MDR: the compounds that were significantly associated with the NSC 361127.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0385613993886001 0.25050892
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0385613993886001 0.094888293
NSC 23925 Null 0.0385613993886001 0.2352671
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0385613993886001 0.075170341
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0385613993886001 0.22613421
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.29864724
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0385613993886001 0.25325253
NSC 619030 Analog of CC-1065 0.0385613993886001 0.39283708
NSC 637505 Null 0.0385613993886001 0.16287179
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0385613993886001 0.18903048
Total:71  Current:46    [First] [Prev] [Next] [Last]